Literature DB >> 33586764

Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.

Christina Weyer-Jamora1,2, Melissa S Brie1,2, Tracy L Luks3, Ellen M Smith1, Shawn L Hervey-Jumper1, Jennie W Taylor1,4.   

Abstract

Intrinsic brain tumors often occur within functional neural networks, leading to neurological impairment and disability of varying degrees. Advances in our understanding of tumor-network integration, human cognition and language processing, and multiparametric imaging, combined with refined intraoperative tumor resection techniques, have enhanced surgical management of intrinsic brain tumors within eloquent areas. However, cognitive symptoms impacting health-related quality of life, particularly processing speed, attention, concentration, working memory, and executive function, often persist after the postoperative recovery period and treatment. Multidisciplinary cognitive rehabilitation is the standard of care for addressing cognitive impairments in many neurological diseases. There is promising research to support the use of cognitive rehabilitation in adult brain tumor patients. In this review, we summarize the history and usefulness of postacute cognitive rehabilitation for adult brain tumor patients. © Congress of Neurological Surgeons 2021.

Entities:  

Keywords:  Brain tumor; Cognitive outcomes; Cognitive rehab; Cognitive rehabilitation; Eloquent area brain tumors; Glioma; Neurocognitive outcomes; Primary brain tumor

Mesh:

Year:  2021        PMID: 33586764      PMCID: PMC8600173          DOI: 10.1093/neuros/nyaa552

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   5.315


  95 in total

Review 1.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

Review 2.  Functional rehabilitation and brain tumour patients. A review of outcome.

Authors:  M T Giordana; E Clara
Journal:  Neurol Sci       Date:  2006-09       Impact factor: 3.307

3.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Authors:  Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans
Journal:  Lancet Neurol       Date:  2009-08-07       Impact factor: 44.182

4.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

5.  Post-surgical effects on language in patients with presumed low-grade glioma.

Authors:  M Antonsson; A Jakola; F Longoni; L Carstam; L Hartelius; M Thordstein; M Tisell
Journal:  Acta Neurol Scand       Date:  2017-12-18       Impact factor: 3.209

Review 6.  Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors.

Authors:  Kyle R Noll; Mariana E Bradshaw; Michael W Parsons; Erica L Dawson; Jennie Rexer; Jeffrey S Wefel
Journal:  Curr Treat Options Neurol       Date:  2019-06-28       Impact factor: 3.598

7.  Semantic strategy training increases memory performance and brain activity in patients with prefrontal cortex lesions.

Authors:  Eliane C Miotto; Cary R Savage; Jonathan J Evans; Barbara A Wilson; Maria G M Martin; Joana B Balardin; Fabio G Barros; Griselda Garrido; Manoel J Teixeira; Edson Amaro Junior
Journal:  Clin Neurol Neurosurg       Date:  2012-06-28       Impact factor: 1.876

8.  Neurocognitive functioning in patients with glioma of the left and right temporal lobes.

Authors:  Kyle R Noll; Mateo Ziu; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  J Neurooncol       Date:  2016-03-29       Impact factor: 4.130

9.  Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.

Authors:  Kyle R Noll; Mariana E Bradshaw; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  Psychooncology       Date:  2015-12-17       Impact factor: 3.894

10.  IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

Authors:  C Houillier; X Wang; G Kaloshi; K Mokhtari; R Guillevin; J Laffaire; S Paris; B Boisselier; A Idbaih; F Laigle-Donadey; K Hoang-Xuan; M Sanson; J-Y Delattre
Journal:  Neurology       Date:  2010-10-26       Impact factor: 11.800

View more
  7 in total

1.  Quality of life following awake surgery depends on ability of executive function, verbal fluency, and movement.

Authors:  Riho Nakajima; Masashi Kinoshita; Hirokazu Okita; Mitsutoshi Nakada
Journal:  J Neurooncol       Date:  2021-11-20       Impact factor: 4.130

2.  Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma.

Authors:  Alexander A Aabedi; Jacob S Young; Yalan Zhang; Simon Ammanuel; Ramin A Morshed; Cecilia Dalle Ore; Desmond Brown; Joanna J Phillips; Nancy Ann Oberheim Bush; Jennie W Taylor; Nicholas Butowski; Jennifer Clarke; Susan M Chang; Manish Aghi; Annette M Molinaro; Mitchel S Berger; Shawn L Hervey-Jumper
Journal:  Neurosurgery       Date:  2022-01-01       Impact factor: 5.315

3.  Cognitive preservation following awake mapping-based neurosurgery for low-grade gliomas: A longitudinal, within-patient design study.

Authors:  Anne-Laure Lemaitre; Guillaume Herbet; Sam Ng; Sylvie Moritz-Gasser; Hugues Duffau
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas.

Authors:  Tracy L Luks; Javier E Villanueva-Meyer; Christina Weyer-Jamora; Karin Gehring; Angela Jakary; Shawn L Hervey-Jumper; Steve E Braunstein; Paige M Bracci; Melissa S Brie; Ellen M Smith; Susan M Chang; Jennie W Taylor
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

Review 5.  Neuro-Oncology Patients as Human Research Subjects: Ethical Considerations for Cognitive and Behavioral Testing for Research Purposes.

Authors:  Jasleen Kaur; Andrew Egladyous; Claudia Valdivia; Andy G S Daniel; Saritha Krishna; Alexander A Aabedi; David Brang; Shawn L Hervey-Jumper
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

6.  Mid-term treatment-related cognitive sequelae in glioma patients.

Authors:  Sabine Schlömer; Jörg Felsberg; Milena Pertz; Bettina Hentschel; Markus Löffler; Gabriele Schackert; Dietmar Krex; Tareq Juratli; Joerg Christian Tonn; Oliver Schnell; Hartmut Vatter; Matthias Simon; Manfred Westphal; Tobias Martens; Michael Sabel; Martin Bendszus; Nils Dörner; Klaus Fliessbach; Christian Hoppe; Guido Reifenberger; Michael Weller; Uwe Schlegel; For The German Glioma Network
Journal:  J Neurooncol       Date:  2022-07-07       Impact factor: 4.506

7.  Long-Term Outcomes of Patients with Primary Brain Tumors after Acute Rehabilitation: A Retrospective Analyses of Factors.

Authors:  Matthew Rong Jie Tay; Justin Desheng Seah; Karen Sui Geok Chua
Journal:  Life (Basel)       Date:  2022-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.